Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):215–221. doi: 10.1097/MPG.0b013e3182a98df2

Figure 3.

Figure 3

Baseline BMI z-score (A), serum albumin (B) and ESR (C) in patients requiring versus those not requiring infliximab dose escalation. Lines and error bars represent median and interquartile range, respectively.